Corrigendum to "Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-κB pathway in human epidermoid carcinoma A431 cells" [Biochem. Biophys. Res. Commun. 384 (2009) 215-220] (DOI:10.1016/j.bbrc.2009.04.100);Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-κB pathway in human epidermoid carcinoma A431 cells

Biochemical and Biophysical Research Communications

Volumn 384, Issue 2, 2009, Pages 215-220

  Roy, Preeti ^a   Kalra, Neetu ^a   Nigam, Nidhi ^a   George, Jasmine ^a   Ray, Ratan Singh ^a   Hans, Rajendra K ^a   Prasad, Sahdeo ^a   Shukla, Yogeshwer ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

A431 cells; NF B; Resveratrol; UV radiation

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIM KINASE 1; RESVERATROL; SERINE; STAT1 PROTEIN; SURVIVIN; TYROSINE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL DEATH; CELL NUCLEUS; CELL PROLIFERATION; DRUG EFFECT; HUMAN; HUMAN CELL; INHIBITION KINETICS; METASTASIS; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; REGULATORY MECHANISM; SENSITIZATION; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET B RADIATION;

EID: 65549134823     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.009     Document Type: Erratum

References (33)

1. Aziz M.H., Kumar R., and Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23 (2003) 17-28
2. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur. J. Endocrinol. 138 (1998) 619-620
3. Sun A.Y., Simonyi A., and Sun G.Y. The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32 (2002) 314-318
4. Baliga M.S., and Katiyar S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. photobio. Sci. 5 (2006) 243-253
5. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
6. Cal C., Garban H., Jazirehi A., Yeh C., Mizutani Y., and Bonavida B. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr. Med. Chem. Anticancer Agents 3 (2003) 77-93
7. Shaw R., Afaq S.F., Aziz M.H., and Ahmad N. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 23 (2004) 5151-5160
8. Afaq F., Adhami V.M., and Ahmad N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 186 (2003) 28-37
9. Jang M., and Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Drugs Exp. Clin. Res. 25 (1999) 65-77
10. Jang M., and Pezzuto J.M. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 13 (1998) 481-489
11. Kulms D., and Schwarz T. Molecular mechanisms of UV-induced apoptosis. Photodermatol. Photoimmunol. Photomed. 16 (2000) 195-201
12. Zeise E., Weichenthal M., Schartz T., and Kulms D. Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet B radiation via downregulation of FLIP. J. Invest. Dermatol. 123 (2004) 746-754
13. Kim D.S., Jeong Y.M., Moon S.I., Kim S.Y., Kwon S.B., Park E.S., Youn S.W., and Park K.C. Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells. Cell. Mol. Life Sci. 63 (2006) 2661-2668
14. Mohan S., Dhanalakshmi S., Mallikarjuna G.U., Singh R.P., and Agarwal R. Silibinin modulates UVB-induced apoptosis via mitochondrial proteins, caspases activation, and mitogen-activated protein kinase signaling in human epidermoid carcinoma A431 cells. Biochem. Biophys. Res. Commun. 320 (2004) 183-189
15. Serpi R., Piispala J., Jarvilehto M., and Vahakangas K. Thapsigargin has similar effect on p53 protein response to benzo(a)pyrene DNA adducts as TPA in mouse skin. Carcinogenesis 20 (1999) 1755-1760
16. Arora A., Siddiqui I.A., and Shukla Y. Modulation of p53 in 7, 12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice. Mol. Cancer Ther. 3 (2004) 1459-1466
17. Lowry O.H., Rosenbrough N.K., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Arora A., Kalra N., and Shukla Y. Regulation of p21/ras protein expression by diallyl sulfide in DMBA induced neoplastic changes in mouse skin. Cancer Lett. 242 (2006) 28-36
19. Aziz M.H., Shaw S.R., Wu J., Longley B.J., and Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?. FASEB J. 19 (2005) 1193-1195
20. Kim J.K., Kim Y., Na K.M., Surh Y.J., and Kim T.Y. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Rad. Res. 41 (2007) 603-614
21. Carmody R.J., and Chen Y.H. Nuclear factor-κB: activation and regulation during toll-like receptor signaling. Cell. Mol. Immunol. 4 (2007) 31-41
22. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappaB. Annu. Rev. Cell Biol. 10 (1994) 405-455
23. Gilmore T.D., Koedood M., Piffat K.A., and White D.W. Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 13 (1996) 1367-1378
24. Neumann M., Marienfeld R., and Serfling E. Rel/NF-κB transcription factors and cancer: oncogenesis by dysregulated transcription. Int. J. Oncol. 11 (1997) 1335-1347
25. Sen C.K., and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10 (1996) 709-720
26. Gamero A.M., Young H.A., and Wiltrout R.H. Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?. Cancer Cell. 5 (2004) 111-112
27. Kanda N., Seno H., Konda Y., Marusawa H., Kanai M., Nakajima T., Kawashima T., Nanakin A., Sawabu T., Uenoyama Y., Sekikawa A., Kawada M., Suzuki K., Kayahara T., Fukui H., Sawada M., and Chiba T. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23 (2004) 4921-4929
28. Lauffenburger D.A., and Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 84 (1996) 359-369
29. Mitchison T.J., and Cramer L.P. Actin-based cell motility and locomotion. Cell 84 (1996) 371-379
30. Arber S., Barbayannis F.A., Hanser H., Schneider C., Stanyon C.A., Bernard O., and Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393 (1998) 805-809
31. Yang N., Higuchi O., Ohashi K., Nagata K., Wada A., Kangawa K., Nishida E., and Mizuno K. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393 (1998) 809-812
32. Davila M., Frost A.R., Grizzle W.E., and Chakrabarti R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells. J. Biol. Chem. 278 (2003) 36868-36875
33. Yoshioka K., Foletta V., Bernard O., and Itoh K. A role of LIM kinase in cancer invasion. Proc. Natl. Acad. Sci. USA 100 (2003) 7247-7252